Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Sales $ 440,495 $ 1,277,923
Cost of sales (228,610) (575,962)
Gross profit 211,885 701,961
Operating Expenses    
Selling and marketing 111,438 97,902
General and administrative 1,377,724 1,952,275
Depreciation and amortization 49,580 6,739
Total operating expenses 1,538,742 2,056,916
Loss from Operations (1,326,857) (1,354,955)
Other Expense (Income)    
Interest expense, net 121,623 70,159
Gain on foreign currency translation (47,523)
Total other expense 74,100 70,159
Net Loss (1,400,957) (1,425,114)
Series B preferred stock dividends (177,795) (155,791)
Net Loss Attributable to Common Stockholders $ (1,578,752) $ (1,580,905)
Net loss per common share $ (0.03) $ (0.04)
Weighted Average Number of Common Shares Outstanding:    
Basic and Diluted 47,818,263 43,086,927